Rongqing Q. Li

Kunming, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Impact of oxidative stress on malignant tumor progression and emerging therapeutic strategies.

Impact of oxidative stress on malignant tumor progression and emerging therapeutic strategies.

Journal: Frontiers in molecular biosciences
Published: June 23, 2026

Postoperative Adjuvant Chemoradiotherapy ± PD-1 Inhibitor for Locally Advanced Head and Neck Squamous Cell Carcinoma.

Postoperative Adjuvant Chemoradiotherapy ± PD-1 Inhibitor for Locally Advanced Head and Neck Squamous Cell Carcinoma.

Journal: Cancer reports (Hoboken, N.J.)
Published: July 30, 2025

PEITC restores chemosensitivity in cisplatin-resistant non-small cell lung cancer by targeting c-Myc/miR-424-5p.

PEITC restores chemosensitivity in cisplatin-resistant non-small cell lung cancer by targeting c-Myc/miR-424-5p.

Journal: Discover oncology
Published: March 29, 2025

Toripalimab in combination with HBM4003, an anti-CTLA-4 heavy chain-only antibody, in advanced melanoma and other solid tumors: an open-label phase I trial.

Toripalimab in combination with HBM4003, an anti-CTLA-4 heavy chain-only antibody, in advanced melanoma and other solid tumors: an open-label phase I trial.

Journal: Journal for immunotherapy of cancer
Published: September 08, 2024

Deciphering the tumor-suppressive role of RBMS3 in lung adenocarcinoma through genomic insights into prognosis and mechanisms.

Deciphering the tumor-suppressive role of RBMS3 in lung adenocarcinoma through genomic insights into prognosis and mechanisms.

Journal: Scientific reports
Published: August 22, 2024

Revolutionizing medicine: Harnessing plant-derived vesicles for therapy and drug transport.

Revolutionizing medicine: Harnessing plant-derived vesicles for therapy and drug transport.

Journal: Heliyon
Published: April 09, 2024

TP53 mitigates cisplatin resistance in non-small cell lung cancer by mediating the effects of resistant cell-derived exosome mir-424-5p.

TP53 mitigates cisplatin resistance in non-small cell lung cancer by mediating the effects of resistant cell-derived exosome mir-424-5p.

Journal: Heliyon
Published: November 28, 2023

Rhabdoid meningioma with a history of Budd-Chiari syndrome: a case report and review of the literature.

Rhabdoid meningioma with a history of Budd-Chiari syndrome: a case report and review of the literature.

Journal: Frontiers in oncology
Published: April 20, 2023

Atypical primary malignant melanoma originating in the spinal canal: A case report and literature review.

Atypical primary malignant melanoma originating in the spinal canal: A case report and literature review.

Journal: Oncology letters
Published: March 20, 2023

Knockdown of mitochondrial threonyl-tRNA synthetase 2 inhibits lung adenocarcinoma cell proliferation and induces apoptosis.

Knockdown of mitochondrial threonyl-tRNA synthetase 2 inhibits lung adenocarcinoma cell proliferation and induces apoptosis.

Journal: Bioengineered
Published: February 21, 2022

Extraskeletal osteosarcoma in lymph nodes: a case report

Extraskeletal osteosarcoma in lymph nodes: a case report

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: July 21, 2021

Whole-brain radiotherapy with and without concurrent erlotinib in NSCLC with brain metastases: a multicenter, open-label, randomized, controlled phase III trial.

Whole-brain radiotherapy with and without concurrent erlotinib in NSCLC with brain metastases: a multicenter, open-label, randomized, controlled phase III trial.

Journal: Neuro-oncology
Published: December 17, 2020
Showing 1-12 of 15

Last Updated: 09/26/2026